Results 101 to 110 of about 22,174 (220)

A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX™ in healthy children

, 2002
This study compared safety, tolerability, and immunogenicity of the Oka/Merck varicella vaccine and VARILRIX™ [Oka-RIT strain SmithKline Beecham Biologicals] in healthy children 12-24 months of age.
Lee, CY, Li, S., Lee, C.-Y., Lin, T.-Y., Lin, TY, Chan, CY, Vessey, S.J.R., Golie, A, Lau, Y.-L., Kaplan, KM, Lee, TL, Distefano, D.J., Matthews, H., Golie, A., Chan, I.S.F., Lee, T.-L., Xu, J, Sadoff, J.C., Kwan, K., Huang, LM, Vessey, SJR, Chan, C.Y., Xu, J., Distefano, DJ, Shaw, A., Sadoff, JC, Kasim, S.M., Lau, YL, Lee, BW, Kasim, SM, Chan, ISF, Shaw, A, Huang, L.-M., Harmon, A.L., Matthews, H, Hartzel, J, Lee, B.W., Kwan, K, Kaplan, K.M., Harmon, AL, Li, S, Hartzel, J.   +41 more
core   +1 more source

Expanded spectrum of varicella disease and the need for vaccination in India

Human Vaccines & Immunotherapeutics
Varicella vaccine was first licensed in Japan and South Korea in 1989 for use in healthy children and was introduced in US in 1995. So far, 29 countries have adopted varicella vaccine in their universal immunization program (UIP). No Asian country, India
Padma Srikanth, Ilakkiya Arumugam, Seetha N. Jeganathan, Rithvik Ramesh, Lakshmi Narasimhan Ranganathan, Shanthi Vijayaraghavan   +5 more
doaj   +1 more source

Measles, Mumps, Rubella, and Varicella Combination Vaccine: Safety and Immunogenicity Alone and in Combination with Other Vaccines Given to Children

, 2020
Eight hundred and twelve children, 12 months to 3.5 years of age, were enrolled in two clinical studies to evaluate the safety and immunogenicity of a live, attenuated combination vaccine for measles, mumps, rubella, and varicella (MMRV).
Brenda Staehle, Holly Matthews, Diane Stinson, Paul Keller, Iksung Cho, C Jo White, Joseph Eiden,', Angela Ngai, Vaccine Study Group! Barbara Kuter   +8 more
core  

Vaccine-era varicella epidemiology and vaccine effectiveness in a public elementary school population, 2002-2007

, 2008
Objective: We conducted ongoing varicella surveillance of public elementary school students to track changes in incidence from 2002 to 2007. In school year 2002–2003, we also conducted a retrospective cohort study to measure varicella vaccine ...
Lee, L., Fratto, J., Cieslak, P., Perkins, Sarah, Lorber, E., Ho, H.   +5 more
core   +1 more source

Reply letter: trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015

Human Vaccines & Immunotherapeutics, 2019
In the letter, Lai SW suggested that the cost-benefit of two-dose varicella vaccines should be considered since universal one-dose vaccination effectively reduced varicella incidence in Taiwan.
Sun Hee Park, Jae-Ki Choi, Sanghyun Park, Su-Mi Choi, Si-Hyun Kim, Dong-Gun Lee, Jin-Hong Yoo, Jung-Hyun Choi, Jin Han Kang   +8 more
doaj   +1 more source

Modelling the impact of varicella vaccination on varicella and zoster

Epidemiology and Infection, 2009
SUMMARYIt has been suggested that the incidence of herpes zoster may increase due to lack of natural boosting under large-scale vaccination with the varicella vaccine. To study the possibility and magnitude of such negative consequences of mass vaccination, we built a mathematical model of varicella and zoster epidemiology in the Finnish population ...
M, Karhunen, T, Leino, H, Salo, I, Davidkin, T, Kilpi, K, Auranen   +5 more
openaire   +2 more sources

Vaccine [PDF]

BackgroundTwo-dose varicella vaccination has been available in Beijing since 2012 in the private sector. We investigated a varicella outbreak in a highly vaccinated elementary school population.MethodsA cohort study was carried out and a varicella case ...

core  

Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study

Bulletin of the World Health Organization
Objective To examine trends in varicella and herpes zoster (HZ) hospitalization following the availability and subsequent National Immunization Programme funding of one-dose varicella vaccination in Australia. Methods Varicella vaccination coverage for
Anita E Heywood, Han Wang, Kristine K Macartney, Peter McIntyre   +3 more
doaj   +1 more source

Varicella vaccination in the immunocompromised [PDF]

Rheumatology, 2014
Ritu, Malaiya, Sanjeev, Patel, Neil, Snowden, Pamela, Leventis   +3 more
openaire   +2 more sources

A Comparison of Safety, Tolerability and Immunogenicity of Oka/Merck Varicella Vaccine and Varilrix(Tm) in Healthy Children

, 2008
This study compared safety, tolerability, and immunogenicity of the Oka/ Merck varicella vaccine and VARILRIX(TM) [Oka- RIT strain SmithKline Beecham Biologicals] in healthy children 12-24 months of age.
黃立民, HUANG, LI-MIN
core